Financials data is unavailable for this security.
View more
Year on year International Stem Cell Corp had revenues fall -4.78% from 8.18m to 7.79m, though the company grew net income from a loss of 331.00k to a smaller loss of 131.00k.
Gross margin | 58.62% |
---|---|
Net profit margin | -8.22% |
Operating margin | -6.61% |
Return on assets | -12.02% |
---|---|
Return on equity | -- |
Return on investment | -84.86% |
More ▼
Cash flow in USDView more
In 2023, International Stem Cell Corp increased its cash reserves by 114.02%, or 846.00k. The company earned 929.00k from its operations for a Cash Flow Margin of 11.93%. In addition the company used 83.00k on investing activities while cash flow from financing was even.
Cash flow per share | -0.0612 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0355 |
---|---|
Tangible book value per share | -0.0592 |
More ▼
Balance sheet in USDView more
Current ratio | 0.7602 |
---|---|
Quick ratio | 0.4785 |
Total debt/total equity | 12.40 |
---|---|
Total debt/total capital | 0.9254 |
More ▼